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ABSTRACT 
The influence of dietary nitrate (NO3-) supplementation on indices of maximal sprint and 
intermittent exercise performance is unclear. Purpose: To investigate the effects of NO3- 
supplementation on sprint running performance, and cognitive function and exercise 
performance during the sport-specific Yo-Yo Intermittent Recovery level 1 test (IR1). 
Methods: In a double-blind, randomised, crossover study, 36 male team-sport players 
received NO3--rich (BR; 70 mL·day-1; 6.4 mmol of NO3-), and NO3--depleted (PL; 70 
mL·day-1; 0.04 mmol NO3-) beetroot juice for 5 days. On day 5 of supplementation, subjects 
completed a series of maximal 20-m sprints followed by the Yo-Yo IR1. Cognitive tasks 
were completed prior to, during and immediately following the Yo-Yo IR1.  Results: BR 
improved sprint split times relative to PL at 20 m (1.2%; BR 3.98±0.18 vs. PL 4.03±0.19 s; 
P<0.05), 10 m (1.6%; BR 2.53±0.12 vs. PL 2.57±0.19 s; P<0.05) and 5 m (2.3%; BR 
1.73±0.09 vs. PL 1.77±0.09 s; P<0.05). The distance covered in the Yo-Yo IR1 test improved 
by 3.9% (BR 1422±502 vs. PL 1369±505 m; P<0.05). The reaction time to the cognitive 
tasks was shorter in BR (615±98 ms) than PL (645±120 ms; P<0.05) at rest but not during the 
Yo-Yo IR1. There was no difference in response accuracy. Conclusions: Dietary NO3- 
supplementation enhances maximal sprint and high-intensity intermittent running 
performance in competitive team sport players. Our findings suggest that NO3- 
supplementation has the potential to improve performance in single-sprint or multiple-sprint 
(team) sports.  
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INTRODUCTION 
Nitric oxide (NO) is a gaseous signalling molecule that regulates several physiological 
processes that are important to exercise performance, including vasodilation, mitochondrial 
respiration and skeletal muscle contractility (Stamler and Meissner, 2001; Umbrello et al. 
2013). NO can be generated through the nitric oxide synthase (NOS)-catalysed oxidation of 
L-arginine and through the O2-independent, one-electron reduction of nitrite (NO2-).  The 
reduction of NO2- to NO is enhanced in hypoxia and acidosis (Lundberg et al. 2008; van 
Faassen et al. 2009) and, since contracting skeletal muscles become increasingly hypoxic and 
acidic during exercise, NOS activity may be reduced and NO2- reduction may become an 
increasingly important source of NO during exercise (Lundberg and Weitzberg 2010). 
Increasing plasma [NO2-] via NO3- supplementation has been reported to improve muscle 
oxygenation (Bailey et al. 2009; Masschelein et al. 2012), muscle metabolic efficiency 
(Bailey et al. 2010; Larsen et al. 2011; Fulford et al. 2013) and contractile function 
(Hernandez et al, 2012; Haider and Folland et al. 2014; Coggan et al. 2015), and to improve 
endurance exercise capacity at least in participants that are not highly trained (Bailey et al. 
2009; Lansley et al. 2011; Cermak et al. 2012). 
Recent evidence suggests that NO3- supplementation has the potential to preferentially 
enhance physiological responses in type II (fast-twitch), compared to type I (slow-twitch), 
skeletal muscle (Jones, 2014a).  Indeed, increased calcium handling proteins and contractile 
force has been observed in type II, but not type I, mouse skeletal muscle after NO3- 
supplementation (Hernandez et al. 2012).  In addition, NO3- supplementation increased hind 
limb blood flow during exercise in rats, with this additional bulk blood flow being selectively 
directed towards type II muscle fibres (Ferguson et al. 2013). Human studies suggest that 
NO3- supplementation can increase evoked explosive force production (Haider and Folland. 
2014) and maximal voluntary power production (Coggan et al. 2015) in the knee extensors, 
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and can increase maximal sprint cycling power output (Rimer et al. 2015) and 180 m sprint 
running performance (Sandbakk et al., 2015).  However, while these findings suggest that 
NO3- supplementation has the potential to improve sprinting performance, the effects of NO3- 
supplementation on sprint running performance over short distances that reflect those 
exhibited during team sports match-play (10-20 m; Spencer et al. 2004; 2005) have yet to be 
investigated. 
The activity pattern during team sports, such as football, rugby and hockey, is characterised 
by short-duration bouts of high-intensity exercise interspersed with brief recovery periods 
(Spencer et al. 2004).  Since this pattern of high-intensity intermittent exercise is associated 
with significant type II muscle recruitment (Krustrup et al. 2006) and, since NO3- 
supplementation can enhance physiological processes in type II muscle (Hernandez et al. 
2012; Ferguson et al. 2013), NO3- supplementation has the potential to enhance team-sport-
specific high-intensity intermittent exercise performance. Consuming a very large NO3- dose 
(29 mmol) over 36 hours prior to exercise was shown to improve performance during the Yo-
Yo intermittent recovery level 1 test (Yo-Yo IR1; Wylie et al. 2013a), a well-established and 
ecologically valid test widely used to mimic the high-intensity running bouts of football 
match-play (Bangsbo et al. 2008). Performance can also be improved in short-duration 
intermittent cycling sprints after supplementation with a large NO3- dose (~8-13 mmol NO3- 
per day, over 3-7 days; Thompson et al. 2015; Wylie et al. 2016), but not with acute 
consumption of a small NO3- dose (~5 mmol NO3- per day; Martin et al., 2014). However, the 
effects of short-term supplementation with a moderate NO3- dose on performance during a 
team-sport-specific intermittent performance test (i.e., a supplementation procedure that has 
been shown to be effective at improving continuous endurance exercise performance (Bailey 
et al. 2009; 2010; Lansley et al. 2011; Vanhatalo et al. 2010)), remains to be determined.    
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The ability to make quick and accurate decisions whilst simultaneously performing high-
intensity running exercise is a key determinant of team sport performance. It has been 
reported that acute low dose (~5 mmol) NO3- ingestion can increase resting brain blood flow 
and improve resting cognitive performance (Wightman et al. 2015), and that NO3- 
supplementation (12.8 mmol NO3- per day for 7 days) can improve reaction time to cognitive 
tasks during prolonged intermittent sprint-cycling (Thompson et al. 2015). However, the 
effect of NO3- supplementation on cognitive performance during an exercise test that 
simulates the movement patterns of team sport match-play has not been investigated. 
The purpose of this study was to assess the effects of NO3- supplementation on team-sport-
specific exercise performance variables and cognitive function before, during and after a Yo-
Yo IR1 test. We hypothesised that, compared to a placebo supplement, NO3- supplementation 
would: 1) improve sprint running performance; and 2) improve exercise and cognitive 
performance during a Yo-Yo IR1 test.  
METHODS 
Subjects 
Thirty-six male team-sport players from local football, rugby and hockey teams (mean ± SD: 
age 24 ± 4 years, height 1.80 ± 0.07 m, body mass 80 ± 10 kg) volunteered to participate. The 
subjects trained (5-10 hours per week) and participated regularly in university and local 
league competitions. None of the subjects were supplementing their diet with any putative 
ergogenic aid for 6 months prior to the start of the study. Following an explanation of the 
experimental procedures, associated risks, potential benefits and likely value of possible 
findings, subjects gave their written informed consent to participate. The study was approved 
by the Institutional Research Ethics Committee and conformed to the code of ethics of the 
Declaration of Helsinki. 
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Experimental design 
Subjects initially visited the laboratory to be screened and familiarized to the testing 
procedures. This included the Yo-Yo intermittent recovery level 1 test (Yo-Yo IR1) until task 
failure, 20 m sprint efforts and the computer-based cognitive tasks. The total distance covered 
in the Yo-Yo IR1 test was used to calculate the subject’s 75% distance which served as a 
time-point for cognitive assessment in the experimental visits. In a double-blind, randomized, 
crossover design, subjects were then assigned to receive NO3--rich beetroot juice (BR) and a 
NO3--depleted beetroot juice (PL) for 5 days with a wash-out period of 7 days separating the 
two supplementation periods. On day 5 of each supplementation period, subjects completed 
the experimental protocol. 
 
Experimental visits were scheduled at the same time of day (± 2 h). Subjects were instructed 
to record their diet during the 24 h preceding the first experimental visit and to repeat this 
prior to the second visit. They were not specifically asked to refrain from the consumption of 
high-NO3- foods. Subjects were also instructed to arrive at the laboratory ≥3 h post-prandial, 
having avoided strenuous exercise and the consumption of alcohol in the 24 h preceding, and 
caffeine in the 8 h preceding, each experimental visit. For the duration of the study, subjects 
were asked to refrain from taking other dietary supplements, and also to avoid using 
antibacterial mouthwash as this inhibits the reduction of NO3- to NO2- in the oral cavity by 
eliminating commensal bacteria (Govoni et al. 2008).  
 
Supplementation 
Following the initial screening and familiarization visit, subjects were allocated to receive 
concentrated NO3--rich beetroot juice (BR; beetroot juice; ~6.4 mmol of NO3- per 70 mL; 
Beet it, James White Drinks Ltd., Ipswich, UK) or NO3--depleted beetroot juice placebo (PL; 
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placebo beetroot juice; ~0.04 mmol NO3- per 70 mL; Beet it, James White Drinks Ltd., 
Ipswich, UK) in a double-blind, randomized, crossover design. Subjects consumed 1 x 70 mL 
of their allocated supplement each day for 5 days and recorded the timing of each 
supplement. Consumption of each supplement was communicated to the research team via 
text or email. Compliance to the supplementation regimen was also assessed via 
questionnaires during each experimental visit.  On the day of each experimental visit, 
subjects consumed 1 x 70 mL of their allocated daily supplement 2.5 hours prior to arriving 
at the laboratory and commencing the exercise tests.  
 
Exercise protocol 
All exercise tests were performed indoors on a wooden surface on running lanes 2 m wide 
and 20 m long. During experimental visits, subjects first completed five running sprints from 
a stationary start as quickly as possible over a distance of 20 m. Each sprint was separated by 
a period of 30 s walking recovery. Subjects began each sprint with the left foot positioned on 
a starting jump mat (Smartspeed, Fusion Sports, Australia). A timing gate system 
(Smartspeed, Fusion Sports, Australia) positioned at 0, 5, 10 and 20 m provided a randomly 
timed (between 1 and 4 s) flashing light and buzzer sound as stimuli to start each sprint. 
Reaction time to the stimuli, as well as 5, 10 and 20 m split times were recorded. Following a 
5-min period of passive recovery, participants completed the Yo-Yo IR1 test until failure. 
The Yo-Yo IR1 test consisted of running repeated 2 x 20 m intervals, back and forth between 
the start, turn and finish markers at progressively increasing speeds indicated by audio bleeps 
from a portable audio device (see Krustrup et al. 2003). Each 2 x 20 m interval was separated 
by a 10 s active recovery period in which subjects would jog 2 x 5 m indicated by a marker 
placed behind the finishing line. When subjects failed twice to reach the finishing line at the 
time of the respective bleep, distance covered was recorded and used as the test result. Prior 
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to, immediately following, and at 75% of the total distance covered in the familiarisation 
trial, subjects completed a computerised Stroop test (see “cognitive assessment”). 
 
Measurements 
Blood analysis and blood pressure 
Upon arrival at the laboratory, a single resting blood sample (~ 4 mL) was drawn from an 
antecubital vein into a lithium-heparin tube (Vacutainer, Becton-Dickinson, NJ, USA). The 
sample was centrifuged for 8 min at 4,000 rpm and 4°C within 2 min of collection, and the 
plasma was then extracted and stored at −80°C for later determination of [NO3
−] and [NO2−] 
using a modified chemiluminescence technique as previously described (Wylie et al. 2013b). 
Then, following 10 min seated rest in a quiet room, three measurements of blood pressure 
were recorded using an automated sphygmomanometer (Dinamap Pro: GE Medical Systems, 
Tampa, FL). 
 
Cognitive assessment 
Subjects were asked to complete a Stroop test before, at 75% maximal distance and 
immediately following the Yo-Yo IR1 test. The Stroop test was delivered using E-Prime® 
2.0 (Psychology Software Tools, Inc. 2013) and presented on a laptop screen positioned at 
the finish line marker of the Yo-Yo IR1 test. Subjects were instructed to respond as quickly 
and as accurately as possible to a series of text stings, as previously described (Thompson et 
al. 2015), using a custom-made keyboard with response reaction time and accuracy recorded. 
The duration of each Stroop test was 90 s. When the Stroop test was administered at 75% 
maximal distance in the Yo-Yo IR1 test, exercise was discontinued for exactly 2 min to allow 
sufficient time for the subject to position himself for the start of the Stroop test and to return 
to start position for the resumption of the Yo-Yo IR1 test.   
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Statistical analysis 
Differences between PL and BR in resting plasma [NO3−] and [NO2−] were analysed using a 
one-way ANOVA. Differences between PL and BR in distance covered during the Yo-Yo 
IR1 test, blood pressure and mean sprint reaction and performance times were analysed using 
paired-samples t-tests. Differences between PL and BR in reaction time and response 
accuracy to the Stroop tests before, during and after YoIR1 were analyzed using two-way, 
repeated-measures ANOVAs (supplement × time). Significant main and interaction effects 
were followed up with Fisher’s LSD post hocs. Relationships between performance in PL and 
changes in performance following BR were analyzed using Pearson product moment 
correlation coefficients. All values are reported as mean ± SD.  Statistical significance was 
accepted at P < 0.05. 
 
RESULTS 
The BR and PL treatments were well tolerated by the subjects and no adverse events were 
noted during the course of the study. The subjects reported that they complied fully with the 
supplementation protocol and with the instruction to record their diet during the 24 h 
preceding the first experimental visit and to replicate this prior to the second visit. 
Blood pressure, plasma [NO2-] and [NO3-] 
Compared to baseline, resting plasma [NO3-] was elevated by 8-fold following BR (baseline: 
41 ± 20 vs BR: 334 ± 95 μM; P<0.01) but unaltered by PL (44 ± 16 μM M; P>0.05) (Fig. 
1A). Resting plasma [NO3-] was greater in BR compared to PL (P<0.05).  Compared to 
baseline, resting plasma [NO2-] was elevated following BR (baseline: 64 ± 26 vs BR: 222 ± 
130 nM; P<0.01) but unaltered following PL (68 ± 40 nM; P>0.05) (Fig. 1B). Resting plasma 
[NO2-] was greater compared to PL (P<0.01). Systolic BP was lower following BR 
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supplementation (BR 117 ± 7 vs. PL 119 ± 8 mmHg; P<0.05). There was also a trend for a 
reduction in MAP following BR compared to PL (BR 79 ± 15 vs. PL 81 ± 15 mmHg; 
P=0.08). There was no significant difference between BR and PL in diastolic BP (BR 64 ± 6 
vs. PL 65 ± 6 mmHg; P>0.05). 
 
Sprint performance 
Compared to PL, 20 m sprint time was improved by 1.2% following BR supplementation 
(BR 3.98 ± 0.18 vs. PL 4.03 ± 0.19 s; P<0.05; Fig. 2). Moreover, there was a 2.3% and a 
1.6% improvement in 5 m (BR 1.73 ± 0.09 vs. PL 1.77 ± 0.09 s; P<0.05) and 10 m (BR 2.53 
± 0.12 vs. PL 2.57 ± 0.12 s; P<0.05) split times, respectively (Fig. 2). Compared to PL, there 
was also a significant improvement in 5-10 m split time following BR (BR 0.80 ± 0.04 vs. PL 
0.81 ± 0.04 s; P<0.05), but not 10-20 m split time (BR 1.45 ± 0.07 vs. PL 1.46 ± 0.09 s; 
P>0.05). There was a weak but significant negative correlation between sprint performance in 
PL and the change in sprint performance observed following BR supplementation over 5 m (r 
= -0.39; P<0.05), 10 m (r = -0.35; P<0.05) and 20 m (r = -0.37; P<0.05). There was no 
difference between BR and PL in reaction time (BR 0.33 ± 0.19 vs. PL 0.38 ± 0.21 s; P>0.05; 
Fig. 2). There was no effect of testing order on sprint performance (P>0.05). 
 
Yo-Yo IR1 performance 
Compared to PL, the distance covered in the Yo-Yo IR1 test was 3.9% greater following BR 
supplementation (BR 1422 ± 502 vs. PL 1369 ± 505 m; P<0.05; Fig. 3). There was no effect 
of testing order on Yo-Yo IR1 test performance (P>0.05). 
 
Cognitive performance 
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The overall response time to the Stroop tasks was shorter in BR (612 ± 102 ms) compared to 
PL (628 ± 103 ms; P<0.05) corresponding to a 2.6% improvement in speed of reaction. 
Specifically, the greatest improvement in reaction time between BR and PL was observed 
during the cognitive tests performed at rest (BR: 615 ± 98 ms vs PL: 645 ± 120; P<0.05). 
There were no significant improvements in reaction time between BR and PL at the 75% 
distance (BR: 612 ± 104 vs. PL: 621 ± 92 ms; P>0.05) or at exhaustion (BR: 608 ± 106 vs. 
PL: 619 ± 97 ms; P>0.05) during the Yo-Yo IR1 test.  The overall accuracy of response was 
not different between BR (34.7 ± 1.4 correct responses) and PL (34.6 ± 1.5 correct responses) 
(P>0.05) and there were no differences at any specific time point.  
 
DISCUSSION 
The main original finding of this study was that short-term dietary NO3- supplementation 
improved all-out sprint running performance over distances (5 m, 10 m and 20 m) typically 
covered by team sports athletes during match-play. We have also confirmed that dietary NO3-
supplementation can improve performance in the team-sport-specific Yo-Yo IR1 test. Finally, 
our findings indicate that NO3- supplementation improves decision-making reaction time for 
the same response precision at rest, but not during or following team-sport-specific high-
intensity intermittent exercise. Therefore, these findings indicate that short-term dietary NO3- 
supplementation can improve performance during short-duration maximal sprint running and 
high-intensity intermittent running, and support the notion that NO3- supplementation might 
enhance team sport performance. 
 
Both plasma [NO3-] and [NO2-] were elevated following 5 days of NO3- supplementation in 
this study, consistent with previous studies (Larsen et al. 2006; Webb et al. 2008; Bailey et al. 
2009; Vanhatalo et al. 2010). A greater circulating plasma [NO2-] after short-term dietary 
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NO3- supplementation would increase substrate for NO synthesis during exercise.  The lower 
systolic BP reported in this study is also consistent with many (Webb et al. 2008; Kapil et al. 
2010; Vanhatalo et al. 2010), but not all (Larsen et al.  2006), previous studies and supports 
the notion of NO-mediated or NO2--mediated physiological signaling after dietary NO3- 
supplementation. Therefore, the imposed dietary NO3- intervention was successful at 
increasing systemic [NO2-] and the potential for O2-independent NO generation.     
 
The effect of BR on maximal sprint running performance 
Although previous studies have reported improved maximal sprint cycling performance 
(Rimer et al. 2015; Thompson et al. 2015) and 180 m sprint running performance (Sandbakk 
et al. 2015) after NO3- supplementation, our study is the first to demonstrate that NO3- 
supplementation can improve performance during 5, 10 and 20 m sprint running by ~1-2%.  
This finding is important since it suggests that NO3- supplementation can improve sprint 
performance within the exercise mode (i.e., running) and over the distances (5-20 m) that are 
typical of match-play in a wide range of team sports (Spencer et al. 2004; 2005).   
Given the differences that have been reported in explosive force (Haider and Folland. 2014) 
and maximal power of inertial-load cycling (Coggan et al. 2015) following NO3- 
supplementation, it might be anticipated that any ergogenic effect might be accentuated 
during the initial phase of all-out sprinting. Indeed, our findings indicate that the greatest 
improvement in sprint performance (2.3%) occurred over the initial 5 m. Moreover, BR 
continued to enhance speed between 5 m and 10 m. Together with previous observations of 
improved sprint performance (Rimer et al. 2015; Thompson et al. 2015; Sandbakk et al. 
2015), these findings strengthen the evidence base for using NO3- as a nutritional aid to 
enhance aspects of sprint running performance.   
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The improved sprint performance after NO3- supplementation might be a function of the 
effects of NO3- supplementation on force production: 1) in type II muscle and 2) at high 
contraction velocities, since maximal sprinting requires both significant type II muscle 
recruitment and high contraction velocities (Greenhaff et al. 1994).  Specifically, NO3- 
supplementation has been shown to increase force production or performance: 1) during the 
initial stages of high-frequency contractions (Haider and Folland 2014); 2) at high, but not 
low, contraction velocities (Bailey et al. 2015; Coggan et al. 2015); and 3) in type II, but not 
type I, skeletal muscle in association with improved skeletal muscle calcium handling 
(Hernandez et al., 2012).  Therefore, our results are consistent with observations of improved 
contractile function in studies using isolated muscle models and extend these findings to 
suggest that NO3- supplementation can enhance maximal sprint running performance over 
distances typically completed by team sports athletes during competition. 
The effect of BR on performance during the YoYo IR1 test 
Several studies have investigated the effects of NO3- supplementation on high-intensity 
intermittent exercise performance but the results have been ambiguous, likely due to marked 
differences in test protocol and the dose and duration of NO3- supplementation (Aucouturier 
et al. 2015; Bond et al. 2012; Christensen et al. 2013; Martin et al. 2014; Muggeridge et al. 
2013; Thompson et al. 2015; Wylie et al. 2013; 2016). In the present study, we observed a 
3.9% improvement in the Yo-Yo IR1 test, which mimics the high-intensity running bouts of 
football match-play (Bangsbo et al. 2008), after short-term NO3- supplementation.  This 
finding is consistent with our previous observation of improved Yo-Yo IR1 test performance 
(+4.2%) after consuming a large NO3- dose (29 mmol) over 36 hours prior to testing, and 
suggests that a similar performance gain can be achieved by ingesting a moderate NO3- dose 
(6.4 mmol NO3- per day) for 5 days.   
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Given that the reduction of NO2- to NO is potentiated with decreasing O2 tension (Lundberg 
et al. 2008; van Faassen et al. 2009) and that PO2 is lower in type II compared to type I 
muscle (Behnke et al. 2003; McDonough et al. 2005), increasing plasma [NO2-] via NO3- 
supplementation may enhance NO2--derived NO synthesis and thus performance during 
exercise at higher intensities. We have previously reported a fall in plasma [NO2-] during 
high-intensity intermittent exercise following NO3- supplementation (Wylie et al. 2013a; 
Thompson et al. 2015). Moreover, the decline in plasma [NO2-] was correlated to the 
improvement in exercise performance observed in these studies (Wylie et al. 2013a; 
Thompson et al. 2015). Given that circulating NO2- is an important correlate of exercise 
performance both in healthy, recreationally-active subjects (Dreissigacker et al. 2010; Rassaf 
et al., 2007) and in trained subjects (Lansley et al. 2011; Wilkerson et al. 2012), the greater 
Yo-Yo IR1 performance in BR may be attributable to enhanced generation of NO2--derived 
NO during exercise.   
NO3- ingestion has been shown to reduce the adenosine triphosphate (ATP) and 
phosphocreatine (PCr) cost of muscle force production during high-intensity continuous 
(Bailey et al. 2010) and intermittent (Fulford et al. 2013) exercise. Furthermore, NO3- 
supplementation has been reported to attenuate the slowing of PCr recovery observed in 
hypoxia, restoring PCr recovery kinetics following exercise to values observed in normoxia 
(Vanhatalo et al. 2011; 2014). It is known that, with increasing exercise intensity, a greater 
recruitment of type II fibres (Sale et al. 1987; Copp et al. 2010) and a slower rate of 
resynthesis of ATP and PCr in type II fibres between high intensity bouts occurs (Casey et al. 
1996). Therefore, the effects of NO3- supplementation on muscle PCr utilisation during high-
intensity exercise (Bailey et al. 2010; Fulford et al. 2013) and on the rate of muscle PCr 
resynthesis following exercise (Vanhatalo et al. 2011; 2014) may be important determinants 
of the improved high-intensity intermittent exercise performance reported herein.  
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In combination, the improved 5, 10 and 20 m maximal sprint running performance and the 
improved Yo-Yo IR1 performance suggest that short-term NO3- supplementation can 
improve several physical determinants of success in team sports and support the use of NO3- 
supplementation as an ergogenic aid for team sports competitors. There were weak negative 
correlations between sprint performance in the PL condition and the magnitude of the 
improvement in sprint performance with BR supplementation (r = -0.35-0.39), indicating that 
the subjects with the poorest sprint performance benefited more from BR supplementation. 
This observation would be consistent with reports that NO3- supplementation is generally less 
effective in enhancing endurance performance in athletes with high levels of aerobic fitness 
(Wilkerson et al. 2012; Jones, 2014b; Porcelli et al. 2015) although some 20% of elite 
athletes may still respond positively (Christensen et al. 2013; Boorsma et al. 2014). Further 
research is therefore required to determine whether the findings of the present study of 
recreational team sport players can be reproduced in highly-trained team sports athletes 
and/or whether a ‘targeted’ approach to individuals with relatively poor sprint performance 
might be recommended.      
The effect of BR on cognitive performance during the YoYo IR1 test 
There was no change in cognitive function, as inferred from response reaction time and 
accuracy during the Stroop test, during or following the Yo-Yo IR1 test. This finding 
conflicts with our previous observation of improved Stroop test performance (faster response 
reaction time for the same response accuracy) during a prolonged intermittent sprint-cycling 
protocol after NO3- supplementation (Thompson et al. 2015). These conflicting findings 
might be linked to the higher NO3- dose used in our previous study (12.8 mmol NO3- per day 
for 7 days, Thompson et al. 2015) compared to the current study (6.4 mmol NO3- per day for 
5 days). Alternatively, or in addition to different NO3- dosing procedures, these inter-study 
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differences in Stroop test performance might be related to the completion of numerous 
cognitive tests throughout the more lengthy exercise protocol used previously, thus increasing 
test sensitivity (Thompson et al. 2015), compared to the single 90 s Stroop test completed 
during a seated rest within the Yo-Yo IR1 test in the present study. Moreover, cognitive test 
performance typically becomes more variable in a fatigued state, rendering it more difficult to 
ascertain differences in performance between conditions.    
The effect of BR on cognitive performance at rest 
In contrast to results during exercise, NO3- supplementation improved decision-making 
reaction time to the Stroop tasks performed during the resting baseline period. This 
observation is consistent with Wightman et al. (2015) who reported improved cognitive 
function at rest in the serial 3s subtraction task following an acute dose of dietary NO3-. This 
was associated with improved cerebral blood flow in the prefrontal cortex at the onset of the 
task period. Similar to the serial 3s subtraction task, the Stroop task assesses the capacity for 
information processing (Besner and Roberts 2005) and performance in these tasks is related 
to the functioning of the prefrontal cortex. NO is pivotal to a number of cerebral processes 
including neurotransmission, vasodilation and neurovascular coupling (Aamand et al. 2013; 
Iadecola et al. 1999; Piknova et al. 2011; Rifkind et al. 2007). Dietary NO3- has been shown 
to improve regional brain perfusion (Presley et al. 2011), attenuate cerebral O2 extraction 
during mental processing (Thompson et al. 2014), and enhance coupling of cerebral blood 
flow to neuronal activity (Aamand et al. 2013).  Therefore, the modulation of cerebral 
haemodynamics, especially in response to cognitive task performance (Wightman et al. 
2015), may underpin the differences in response time between BR and PL in the present 
study. However, it is somewhat surprising that the greatest improvement in cognitive function 
was observed at rest and not during exercise when the difference between conditions in 
cerebral oxygenation is expected to be more pronounced and the potential for NO generation 
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from NO2- reduction is expected to be increased (Lundberg et al. 2008; van Faassen et al. 
2009). Further studies are required to investigate the effects of NO3- supplementation on 
cerebral oxygenation and cognitive function during high-intensity intermittent exercise.  
Experimental Considerations 
It is important to recognize that the efficacy of putative ergogenic aids in sport is related to a 
host of variables including subject characteristics (sex, age, training status), exercise modality 
and protocol (duration, intensity, continuous or intermittent), and dosing strategy (quantity, 
acute or chronic intake). In this respect, our study indicates that BR supplementation 
improves sprint and intermittent high-intensity exercise performance under the particular 
conditions of our investigation, namely in competitive but sub-elite team sport players 
consuming a moderate dose of NO3- for 5 days. Further clearly-defined and well-executed 
research studies are needed to test the various possible permutations (amongst subject type, 
exercise protocol, and dosing regimen) to better delineate the other circumstances in which 
BR or NO3- supplementation may, or may not be effective. A key strength of the present 
investigation was the recruitment of a large sample size and the employment of validated 
protocols to which the subjects were familiarized prior to commencement of the study. When 
differences between conditions are relatively small (i.e., 1-2% for sprint performance), albeit 
but they are highly meaningful to sports performance outcomes (Hopkins et al. 1999), it is 
clearly important that studies are sufficiently powered to ensure that false conclusions are not 
drawn with regard to supplement efficacy. A limitation to our study was that we were unable 
to control subjects’ diet but relied instead on the subjects recording their food consumption in 
the 24 h prior to the first experimental visit and replicating this prior to the second 
experimental visit . While the subjects reported that they had complied with this requirement, 
future studies might control pre-test diet more rigorously. It should also be noted that our 
study design (daily supplement intake for 4 days plus a final supplement intake 2.5 h before 
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the exercise tests) does not allow us to differentiate between the effects elicited by chronic vs 
acute BR ingestion.       
 
In conclusion, this study has made an important contribution to our understanding of the 
ergogenic potential of dietary NO3- supplementation for sprint and team sports athletes.  
Specifically, our results indicate that short-term supplementation (5 days) with a moderate 
NO3- dose (6.4 mmol NO3- per day) can improve performance in short-duration, all-out sprint 
runs (5-20 m) and high-intensity intermittent runs over distances that closely reflect those that 
are manifest during match-play in team sports such as hockey, football and rugby. Our results 
also indicate that NO3- supplementation can improve cognitive performance (faster response 
reaction time for the same response accuracy) in the Stroop test at rest, but not during or 
following a high-intensity intermittent running test. These findings support the use of NO3- 
supplementation as a nutritional aid to enhance important physical determinants of team sport 
performance.  
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FIGURE LEGENDS 
Figure 1: BR elevated plasma [NO2-] by 248% compared to baseline and 226% compared to 
PL (panel A). BR elevated plasma [NO3-] by 710% compared to baseline and 666% 
compared to PL (panel B). * P<0.001 compared to PL; # P<0.001 compared to baseline. 
Figure 2: Sprint performance was improved in BR compared to PL. * P<0.05. 
Figure 3. The distance covered in the Yo-Yo IR1 test was 3.7% greater in BR compared to 
PL. The dashed lines indicate individual responses and the solid line indicates the group 
mean (±SE). * P<0.05. 
 
 
 
